Member Info for VincentVega

Good morning all. I hope you all had a good Easter weekend with family and friends.

neilin, the information that you provide on this board is invaluable. Your posts also come across as calculated in the sense of accuracy and conformity of certain boundaries.

The fact that you’ve thrown a new and previously unheard of ‘bone’ into the ring, piqued my interest.

Could you elaborate on this project please?

VV

After reading todays RNS and comparing it to the RNS in September, I feel a little hoodwinked.

I guess I’ve only myself to blame for settling in to the collective mantra of patience is the key.

I contributed to the “Next RNS” thread on 18th March. My view was that given previous announcements, the next RNS should be clinical trial results.

This was also based on the assertions from AS that he wouldn’t RNS fluff.

To receive this news this morning after a 6mth news blackout was a bit of a shock and disappointed would be understating it.

It was stated back in September that key milestones had been met to begin clinical trials following the completion of trials design. Clearly todays news conflicts with that claim.

For the avoidance of doubt…

“On 10 August 2023 the Group announced an expansion of its research programme with the University of York to. This followed significant further progress in isolating additional new and specific monoclonal antibodies to the CIZ1B biomarker and incorporating these into a new high-throughput clinical diagnostic immunoassay platform. The recent developments meet key milestones to begin commercial clinical trials. The Company is now engaged in clinical trials design to support the validation and accreditation of the CIZ1B test prior to commercial launch.”

VV

Thanks OAP.

Just watched it.

Frankly, I don’t know why AS bothered. No reason given for the switch.

Does anybody have a link for the interview.

For some reason I can’t find it after numerous searches.

Cheers

VV

I’m busy today, just as well because what I’d post right now wouldn’t be pretty.

The phase 1 trial results were hardly exciting.

I wonder if this was the same trial.

Phase 1.

https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-a-vaccine-called-ast-vac2-for-non-small-cell-lung-cancer

Summary of results.

https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-a-vaccine-called-ast-vac2-for-non-small-cell-lung-cancer#undefined

Gary Middleton

https://www.birmingham.ac.uk/staff/profiles/immunology-immunotherapy/middleton-gary

A very telling post hinting at the future ownership of this as we’ve all suspected.

I wouldn’t say that the new CEO of Cizzle inc is fluff.

Our trader from yesterday having another go today?

Hi Brondby,

I’m rather hoping that they are near complete on the clinical testing given that they stated the following nearly 6 months ago…

“On 10 August 2023 the Group announced an expansion of its research programme with the University of York to. This followed significant further progress in isolating additional new and specific monoclonal antibodies to the CIZ1B biomarker and incorporating these into a new high-throughput clinical diagnostic immunoassay platform. The recent developments meet key milestones to begin commercial clinical trials. The Company is now engaged in clinical trials design to support the validation and accreditation of the CIZ1B test prior to commercial launch.”

Looks like somebody wants out.

I posted the following on here 17th Jan after watching their webinar…

I’ve just watched their webinar.

They’re 6mths behind setting up a cohesive sales structure. They’ll need additional funding in the near term due to this and their less than satisfactory product uptake.

Https://www.businessinsider.com/twitter-bans-bnn-accounts-founded-by-former-tech-ceo-gurbaksh-chahal-2022-6?amp

BNN Breaking is a news website based in Hong Kong launched in 2022 by Indian-American entrepreneur Gurbaksh Chahal. It has been criticised for posting a number of misleading and inaccurate news stories, potentially using AI-driven content aggregation.

That’s actually a weakness, not a strength.

“So, I'm basically cheesed off with myself that a mischief- maker like Fastfood is having an effect; and that's due to my lack of personal power/ information - down to me.”

Good for you for wanting to dig deeper but I wouldn’t concern yourself with fastfood’s cryptic comments.

Apart from getting it from the horses mouth, there is only one other way that he would know who’s selling, but not recently as there are time limits.

Also, if he did know, he’d have said so by now.

Tech, the Company won’t be able to answer your question. (Even in the unlikely event that a significant shareholder has told them they are selling)

As has been previously mentioned, the Company has a duty to keep their significant shareholder list up to date, but they can only rely on the shareholder notifying the Company. No notifications = no change.

Hi fastfood,

Back in early January you said that you had a bit to say on Ciz, but would hold out till Feb/March.

It’s now March.

The 2 year chart on that share looks like something only Eddie The Eagle would enjoy.

Only just joined the dots myself Tech.

Last post anywhere, 13th Feb.